Skip to main content
Clinical Trials/NCT01946451
NCT01946451
Unknown
Not Applicable

Gene Expression and Their Correlations in Patients With Idiopathic and Secondary Epiretinal Membranes in Proliferative Diabetic Retinopathy

Medical University of Silesia1 site in 1 countryJune 2012

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Proliferative Diabetic Retinopathy
Sponsor
Medical University of Silesia
Locations
1
Primary Endpoint
Gene expression in patients with idiopathic and secondary epiretinal membranes in proliferative diabetic retinopathy.
Last Updated
12 years ago

Overview

Brief Summary

The purpose of this study was to investigate the expression of selected genes both in epiretinal membranes (ERMs) and peripheral blood mononuclear cells (PBMCs) from patients with primary and secondary epiretinal membranes in proliferative diabetic retinopathy. Possible correlations between messenger ribonucleic acid (mRNA) levels of these genes were also identified.

Registry
clinicaltrials.gov
Start Date
June 2012
End Date
December 2013
Last Updated
12 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Dorota Romaniuk

MD

Medical University of Silesia

Eligibility Criteria

Inclusion Criteria

  • Caucasian race,
  • both males and females,
  • aged ≥ 55 years,
  • suffering from idiopathic ERMs or secondary ERMs in proliferative diabetic retinopathy (PDR).
  • Presence of ERM was proven in optical coherence tomography (OCT) examination.
  • Exclusion criteria:
  • aged \< 55 years,
  • systemic connective tissue disease,
  • active inflammatory process

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Gene expression in patients with idiopathic and secondary epiretinal membranes in proliferative diabetic retinopathy.

Time Frame: The period between the diagnosis of the ERMs and the actual surgery for the condition was between 2 and 43 months.

Study Sites (1)

Loading locations...

Similar Trials